A7yk4w
A7yk4w
A7yk4w
1. Neurology, Dow University of Health Sciences, Karachi, PAK 2. Medicine, Peoples University of Medical and Health
Sciences for Women, Nawabshah, PAK 3. Internal Medicine, Peoples University of Medical and Health Sciences for
Women, Nawabshah, PAK 4. Medicine, College of Physicians and Surgeons Pakistan, Karachi, PAK 5. General Surgery,
Combined Military Hospital, Karachi, PAK 6. Internal Medicine, King Edward Medical University, Mayo Hospital,
Lahore, PAK 7. Cardiology, Dow University of Health Sciences, Karachi, PAK 8. Internal Medicine, Dow University of
Health Sciences, Karachi, PAK
Abstract
Introduction
Diabetic foot is a common complication of diabetes mellitus (DM). The Wagner classification is mostly used
to grade its severity. The correlation between the hemoglobin A1c (HbA1c) and the Wagner classification is
still controversial. Therefore, the purpose of this study is to determine the correlation of HbA1c with Wagner
classification in patients with diabetic foot.
Results
The mean age of the study population was 47.4 ± 10.6 years. Of the 88 patients, 15 (17.04%) were 25-35 years
of age, 34 (38.63%) were 36-50 years of age, and 39 (44.31%) were 51-65 years of age; 45 (51.13%) patients
were males and 43 (48.86%) patients were females. The mean HbA1c level of the study population was 9.07 ±
Received 06/23/2020
1.65%; 5 (5.68%) patients had 6.5-7.5%, 34 (38.63%) patients had 7.6-8.5%, 24 (27.27%) patients had 8.6-
Review began 06/29/2020 9.5%, and 25 (28.41%) patients had an HbA1c level of >9.5%. Twelve (13.63%) patients had ≤ 7 years, 18
Review ended 07/14/2020 (20.45%) had 8-15 years, and 58 (65.9%) had >15 years of duration of DM. Zero (0%) patients had grade 0, 1
Published 07/15/2020 (1.13%) patient had grade 1, 6 (6.81%) patients had grade 2, 29 (32.95%) patients had grade 3, 32 (36.36%)
© Copyright 2020 patients had grade 4, and 20 (22.72%) patients had grade 5 of Wagner classification. 23 (26.13%) patients
Farooque et al. This is an open access had foot abnormalities, 19 (21.59%) patients had nephropathy, 13 (14.77%) patients had neuropathy, 14
article distributed under the terms of the (15.91%) patients had hypertension, 9 (10.22%) patients had retinopathy, 3 (3.41%) patients had foot
Creative Commons Attribution License
ulcers/toe amputation, 2 (2.27%) patients had a cognitive deficit, and 5 (5.68%) patients had cardiovascular
CC-BY 4.0., which permits unrestricted
use, distribution, and reproduction in any diseases. The correlation of HbA1c with Wagner classification was found statistically significant with p <
medium, provided the original author and 0.00001.
source are credited.
Conclusions
The older age, male gender, longer duration of DM, increased HbA1c, and previously existing foot
abnormalities in diabetic patients are the risk factors of diabetic foot. The monitoring of HbA1c can help
predict the diabetic foot in the aforesaid high-risk diabetics because the HbA1c linearly rises with the higher
grades of Wagner classification of diabetic foot. Subsequently, the strict control of HbA1c as well as patient
education about proper foot care can help prevent diabetic foot and its complications. However, more
studies on larger scales are needed to establish the factual relationship between HbA1c and Wagner
classification.
Introduction
The most frequently used classification system for the diabetic foot that evaluates ulcer depth and bone
involvement is the Wagner classification, which aids in the execution of a proper treatment plan and
estimation of the possible outcomes. The other, not usually applied, classification systems assess ischemia,
neuropathy, and the degree of infection [2,3].
The frequency of diabetic foot ulcers in different regions of the foot and the grades of Wagner classification
has already been defined. Aamir et al. stated that diabetic foot ulcers were at the forefoot in 59%, midfoot in
25%, and hindfoot in 16% of patients [4]. Hasan et al. determined the frequency of grades of Wagner
classification and showed that 5.5% of patients had grade 1, 30% had grade 2, 20% had grade 3, 33.3% had
grade 4, and 11.1% had grade 5 ulcers [5]. Ashraf et al. stated that 74% of patients had grade 2 and grade 3
ulcers, whereas 24% of patients had grade 5 ulcers. They also found that 75% of patients were cured with
limb salvage, whereas 25% could not recover without limb amputation. They also established that 22.6% to
47% of these ulcers were neuropathic, 59% were neuro-ischemic, and 18.3% were ischemic in nature [6].
The current literature is debatable about the correlation between hemoglobin A1c (HbA1c) levels and the
Wagner classification. Therefore, our study is aimed at determining the correlation of HbA1c with different
grades of Wagner classification in patients with diabetic foot.
Data collection
Patients presenting to the outpatient department or admitted to the hospital and meeting the
inclusion/exclusion criteria were enrolled in this study. The pros and cons of the study were explained, and
informed consent was obtained. A blood sample was collected and sent to the institutional laboratory for the
HbA1c level analysis. Grading of the diabetic foot was performed after examination of the wound using
Wagner classification, as shown in Table 1 [7].
Grade Lesion
2 Ulcer extension to the ligament, tendon, joint capsule, or deep fascia without abscess or osteomyelitis
Patient demographics such as age, gender, duration of DM, and other risk factors of foot ulcers (foot
abnormalities, nephropathy, neuropathy, hypertension, retinopathy, foot ulcers/toe amputation, cognitive
deficit, and cardiovascular diseases) were asked by the researcher and entered in the questionnaire.
Data analysis
Data were entered and analyzed using SPSS Version 20 (IBM Corp., Armonk, NY, USA). Mean and the
Results
The mean age of the patients was 47.4 ± 10.6 years, as shown in Table 2.
Of the total 88 patients, 15 (17.04%) patients aged 25-35 years, 34 (38.63%) patients aged 36-50 years, and
39 (44.31%) patients aged 51-65 years, as shown in Figure 1.
There were 45 (51.13%) male and 43 (48.86%) female patients, as shown in Figure 2.
The mean HbA1c level of the patients was 9.07 ± 1.65%, as shown in Table 3.
There were 5 (5.68%) patients with 6.5-7.5%, 34 (38.63%) patients with 7.6-8.5%, 24 (27.27%) patients with
8.6-9.5%, and 25 (28.41%) patients with >9.5% of HbA1c level, as shown in Figure 3.
The duration of DM was ≤7 years in 12 (13.63%) patients, 8-15 years in 18 (20.45%) patients, and >15 years
There were 0 (0%) patients with grade 0, 1 (1.13%) patient with grade 1, 6 (6.81%) patients with grade 2, 29
(32.95%) patients with grade 3, 32 (36.36%) patients with grade 4, and 20 (22.72%) patients with grade 5 of
Wagner classification, as shown in Figure 5.
There were 23 (26.13%) patients with foot abnormalities, 19 (21.59%) patients with nephropathy, 13
(14.77%) patients with neuropathy, 14 (15.91%) patients with hypertension, 9 (10.22%) patients with
retinopathy, 3 (3.41%) patients with foot ulcers/toe amputation, 2 (2.27%) patients with a cognitive deficit,
and 5 (5.68%) patients with cardiovascular diseases. These frequencies of other risk factors of foot ulcers are
shown in Figure 6.
Correlation of HbA1c with Wagner classification showed a statistically significant linear relationship with p
< 0.00001. Mostly, patients with grade 4 and 5 were found to have HbA1c > 8.5%. However, patients with
grades 1-3 also had HbA1c > 6.5%. These findings are shown in Table 4.
6.5-7.5% 1 0 4 0 0
7.6-8.5% 0 6 21 7 0
<0.00001
8.6-9.5% 0 0 4 18 2
>9.5% 0 0 0 7 18
Discussion
This study indicates that there is a linear relationship between the HbA1c level and the grades of Wagner
classification. Patients classified in grades 0-2 of Wagner classification had slightly elevated HbA1c levels,
whereas patients with grades 3-5 had the highest HbA1c levels mainly due to non-compliance of the
patients.
Diabetic foot syndrome includes several diabetic foot pathologies such as infection, neuropathic
osteoarthropathy, and diabetic foot ulcers. Diabetic foot, which is about 15% of these and is projected to
grow up to 25%, is the most hazardous condition, which may lead to limb amputation [8].
Diabetic foot is caused by minor injuries that are not perceived for a long time by diabetic patients due to
peripheral nerve dysfunction. Furthermore, peripheral nerve dysfunction often gets associated with
peripheral arterial disease leading to the deficient blood supply to the limbs, a condition known as diabetic
angiopathy, which may also cause diabetic foot. Therefore, the diabetic foot can be neuropathic, neuro-
ischemic, or ischemic alone [6,9,10].
Zubair et al. and Ozenc et al. established a contradictory correlation between HbA1c level and Wagner
classification. Zubair et al. found a statistically significant, whereas Ozenc et al. found a statistically
insignificant correlation [11,12]. Sarinnapakorn et al. also showed that HbA1c level and fasting plasma
glucose are not markedly related to diabetic foot, but about 50% of type II DM patients had an intermediate
or high risk of diabetic foot. They categorized foot ulcer risk into low, intermediate, and high, each having a
The precautionary measures that patients should be educated about to decrease the incidence of the diabetic
foot include strict glycemic control with lifestyle modification and compliance to medication, regular
screening for foot ulcers, and self-examination for foot skin lesions, fungal infections, and
deformities [1,15,16].
Conclusions
The high-risk diabetic patients for diabetic foot are those with older age, male gender, longer duration of
DM, raised HbA1c, and preexisting foot abnormalities. The HbA1c can be used as a screening tool in the
aforementioned high-risk diabetic patients for the diabetic foot to predict its occurrence, as HbA1c has a
linear relationship with the grades of Wagner classification of diabetic foot. This can help decrease the
incidence of the diabetic foot and its related complications such as amputations, infections, disability, and
death through tighter control of HbA1c and awareness about proper foot care because strict glycemic control
decreases the neuropathic and vascular complications of DM. However, further large-scale studies are
needed to find out the true association between HbA1c and Wagner classification.
Additional Information
Disclosures
Human subjects: Consent was obtained by all participants in this study. Peoples University of Medical and
Health Sciences for Women, Shaheed Benazirabad issued approval PUMHSW/SBA/REGISTRAR:/342/48.
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the
following: Payment/services info: All authors have declared that no financial support was received from
any organization for the submitted work. Financial relationships: All authors have declared that they have
no financial relationships at present or within the previous three years with any organizations that might
have an interest in the submitted work. Other relationships: All authors have declared that there are no
other relationships or activities that could appear to have influenced the submitted work.
References
1. Singh N, Armstrong DG, Lipsky BA: Preventing foot ulcers in patients with diabetes . JAMA. 2005, 293:217-
228. 10.1001/jama.293.2.217
2. Understanding Diabetic Foot Ulcer Classification Systems . (2019). Accessed: April 20, 2020:
https://www.woundsource.com/blog/understanding-diabetic-foot-ulcer-classification-systems.
3. Huang Y, Xie T, Cao Y, et al.: Comparison of two classification systems in predicting the outcome of
diabetic foot ulcers: the Wagner grade and the Saint Elian Wound score systems. Wound Repair Regen.
2015, 23:379-385. 10.1111/wrr.12289
4. Aamir AH, Nasir A, Jadoon MZ, Mehmood K, Ali SS: Diabetic foot infections and their management in a
tertiary care hospital. J Ayub Med Coll Abottabad. 2011, 23:58-62.
5. Hasan F, Rana HN, Ali M, Tahir M, Saleem R: Diabetic foot - assessment and management of 100 cases . Pak J
Med Health Sci. 2011, 5:677-681.
6. Ashraf MN, Rehman K, Malik KI, Iqbal GS: Epidemiology and outcome in patients of diabetic foot . J Ayub
Med Coll Abottabad. 2011, 23:122-124.
7. Wagner FW Jr: The diabetic foot. Orthopedics. 1987, 10:163-172. 10.3928/0147-7447-19870101-28
8. Lauterbach S, Kostev K, Kohlmann T: Prevalence of diabetic foot syndrome and its risk factors in the UK . J
Wound Care. 2013, 19:333-337. 10.12968/jowc.2010.19.8.77711
9. Andrews KL, Houdek MT, Kiemele LJ: Wound management of chronic diabetic foot ulcers: from the basics
to regenerative medicine. Prosthet Orthot Int. 2015, 39:29-39. 10.1177/0309364614534296
10. Gupta SK, Panda S, Singh SK: The etiopathogenesis of the diabetic foot: an unrelenting epidemic . Int J Low
Extrem Wounds. 2010, 9:127-131. 10.1177/1534734610380029
11. Zubair M, Malik A, Ahmad J: Glycosylated hemoglobin in diabetic foot and its correlation with clinical
variables in a North Indian tertiary care hospital. J Diabetes Metab. 2015, 6:571. 10.4172/2155-6156.1000571
12. Ozenç S, Simsek K, Yildirim AO, et al.: Association between the development of diabetic foot and serum
fetuin‑A levels. Pol Arch Med Wewn. 2013, 123:513-518. 10.20452/pamw.1921
13. Sarinnapakorn V, Sunthorntepwarakul T, Deerochanawong C, Niramitmahapanya S, Napartivaumnuay N:
Prevalence of diabetic foot ulcers and risk classifications in type 2 diabetes mellitus patients at Rajavithi
hospital. J Med Assoc Thai. 2016, 99:99-105.
14. Wu L, Hou Q, Zhou Q, Peng F: Prevalence of risk factors for diabetic foot complications in a Chinese tertiary
hospital. Int J Clin Exp Med. 2015, 8:3785-3792.
15. American Diabetes Association: Standards of medical care in diabetes—2017 abridged for primary care
providers. Clin Diabetes. 2017, 35:5-26. 10.2337/cd16-0067